Pence-davis Medical Center Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 2651 S 800 W, Swayzee, IN 46986 Phone: 765-922-7056 Fax: 765-922-7059 |
News Archive
Banyan Biomarkers, Inc., the leader in developing in vitro diagnostic products to detect traumatic brain injury (TBI), announced today that they have been awarded a $26.3 Million Contract for the development of a diagnostic test for TBI.
While the medical community continues to debate the benefits of CYP2D6 genetic testing for women on the breast cancer treatment tamoxifen, patients using the medication are anxious to have the tests. According to a new survey of more than 700 women with breast cancer currently taking tamoxifen, almost 80 percent of respondents would choose to have a genetic test that determines CYP2D6 genotype, yet only 14 percent of these women have been tested. CYP2D6 is an enzyme that influences how well the body processes tamoxifen into its more active form.
Please be advised that Gallup and Healthways, Inc. today released the Gallup-Healthways Monthly U.S. Well-Being Report for December 2010.
State public health departments do not necessarily lose funding when merged with larger Medicaid programs, according to a just-released study. The findings from this first-of-a-kind research should help allay concerns that when such mergers occur they automatically lead to cutbacks in public health, says lead author Paula Lantz, PhD, who is chair of the Department of Health Policy at the George Washington University School of Public Health and Health Services (SPHHS).
The slogan meant to increase sun protection use – "Slip! Slop! Slap! and Wrap" may be losing its touch – especially in kids. Despite numerous efforts to encourage people to wear sunscreen, a new study shows only 1 in 4 children regularly use sunscreen. Researchers say more than half of the children in the study also reported having a sunburn in the previous summer.
› Verified 4 days ago